WallStSmart
PGEN

Precigen Inc

NASDAQ: PGEN · HEALTHCARE · BIOTECHNOLOGY

$4.20
-7.25% today

Updated 2026-06-05

Market cap
$1.59B
P/E ratio
P/S ratio
50.21x
EPS (TTM)
$-1.21
Dividend yield
52W range
$1 – $5
Volume
4.7M

Precigen Inc (PGEN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-81.76M$-61.53M$-53.68M$-19.86M$35.67M$-55.98M$-104.14M$-124.24M$-77.02M$-77.02M$-55.77M$-65.05M$-66.93M$-68.17M$-87.83M
Capital expenditures$13.00M$7.49M$1.53M$6.37M$12.75M$31.63M$46.67M$41.59M$7.53M$7.53M$7.25M$4.92M$1.54M$8.58M$2.00M
Depreciation
Stock-based comp$992000.00$1.55M$3.04M$22.34M$100.42M$52.98M$52.69M$46.99M$18.37M$18.37M$13.90M$10.21M$9.89M$9.47M$10.87M
Free cash flow$-94.76M$-69.02M$-55.21M$-26.23M$22.92M$-87.60M$-150.81M$-165.83M$-84.55M$-84.55M$-63.02M$-69.97M$-68.47M$-76.76M$-89.83M
Investing cash flow
Financing cash flow
Dividends paid$150.91M$6.98M$41.98M$7.73M
Share repurchases
Debt repayment
Net change in cash$-22.04M$108.32M$-73.17M$5.50M$34.34M$-40.94M$-16.54M$-9.12M$6.08M

Frequently asked questions

What is Precigen Inc's revenue?

Precigen Inc's trailing twelve-month revenue is $31.59M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is PGEN?

In its most recent fiscal year, PGEN ran a gross margin of 37.05%, an operating margin of -1,100.78%, and a net margin of -2,588.21%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does PGEN generate?

PGEN produced $-89.83M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PGEN's balance sheet healthy?

PGEN holds $30.23M in cash and equivalents against $93.17M in long-term debt, on $20.91M of shareholder equity. That debt is best read against the cash flow the business throws off each year.